APA (7th ed.) Citation

Kajol, A, C., A, B., P, S., SJ, P., & RK, P. (2026). Cisproplatin: A Redox-Activatable Cisplatin-Probenecid Pt(IV) Conjugate with Broad NCI-60 Potency that Decouples Antitumor Efficacy from Dose-Limiting Toxicity and Suppresses CIPN. Journal of medicinal chemistry, 69(14), 16601. https://doi.org/10.1021/acs.jmedchem.6c00253

Chicago Style (17th ed.) Citation

Kajol, Choudhury A, Banerjee A, Shukla P, Panda SJ, and Pathak RK. "Cisproplatin: A Redox-Activatable Cisplatin-Probenecid Pt(IV) Conjugate with Broad NCI-60 Potency That Decouples Antitumor Efficacy from Dose-Limiting Toxicity and Suppresses CIPN." Journal of Medicinal Chemistry 69, no. 14 (2026): 16601. https://doi.org/10.1021/acs.jmedchem.6c00253.

MLA (9th ed.) Citation

Kajol, et al. "Cisproplatin: A Redox-Activatable Cisplatin-Probenecid Pt(IV) Conjugate with Broad NCI-60 Potency That Decouples Antitumor Efficacy from Dose-Limiting Toxicity and Suppresses CIPN." Journal of Medicinal Chemistry, vol. 69, no. 14, 2026, p. 16601, https://doi.org/10.1021/acs.jmedchem.6c00253.